Reviews
Average rating: 4/5
Other Medical Provider ( 1 )
-
5
-
4
-
3
-
2
-
1
Average rating: 5/5
Physician ( 1 )
-
5
-
4
-
3
-
2
-
1
Average rating: 4.50/5
Total Reviews: 2
-
5
-
4
-
3
-
2
-
1
Desmopressin is first-line therapy for type 1 VWD and some type 2 cases, if the patient is responsive. It requires refrigeration, and among administration routes, IV is most reliable, followed by subcutaneous injection and then nasal spray, which has more variable absorption.
1
Desmopressin (DDAVP) works by releasing von Willebrand factor stored in cells near blood vessels, but its effect may be limited if cellular stores are low. Availability has been limited since a 2020 recall, though production is improving through partnerships like HFA and STAQ Pharma, with FDA clearance in 48 states. Insurance coverage remains slow to expand.
0